提高生物可用性:口服异思氨酸配方的进展
1Schulich School of Medicine and Dentistry, Western University, Windsor, ON, Canada.
口服的异二胺有效治疗,但存在风险. 新的微缩配方改善了生物可用性的一致性,可能简化剂量并改善患者的治疗结果.
科学领域:
- 皮肤病学 皮肤病学
- 制药科学 制药科学
- 药物输送系统 药物输送系统
背景情况:
- 口服的异二因在方面非常有效,但存在诸如致性等风险.
- 原始配方的生物可用性在食和禁食状态之间存在显著差异,使剂量复杂化.
- 配方的进步旨在减少这种变化并提高治疗的一致性.
研究的目的:
- 评估配方进步对口服异二胺生物可用性的影响.
- 为了比较原始剂,利多斯封装和微缩配方之间的食/禁食生物利用率差异.
- 评估微缩能否改善剂量确定以获得最佳治疗结果.
主要方法:
- 对不同口服异二氨酸配方的生物可用性数据进行比较分析.
- 评估与养条件相对的禁食生物利用率差异.
- 基于生物可用性数据,评估微化配方所需的剂量调整.
主要成果:
- 快速的生物利用率降低了60%的原始剂,33%的 lidose-encapsulated,和20%的微化异丁氨酸.
- 微缩配方具有更高的整体生物可用性,需要减少20%的剂量.
- 通过微缩来减少食物效应的变化,可能有助于精确的剂量选择.
结论:
- 微化口服异二胺显著降低了生物可用性变化,提供了更可预测的药物暴露.
- 这种改进的配方一致性可以导致更准确的剂量和潜在的更好的患者在管理的结果.
- 进一步的研究可能会证实微化异二在优化治疗中的临床实用性.
更多相关视频
06:02Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination
Published on: February 23, 2024
12:12Transformation of Probiotic Yeast and Their Recovery from Gastrointestinal Immune Tissues Following Oral Gavage in Mice
Published on: February 8, 2016
相关概念视频
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Factors Influencing Bioavailability: First-Pass Elimination
Bioavailability: Overview
Factors Influencing Drug Absorption: Presystemic Elimination
Factors Influencing Drug Absorption: Physicochemical Parameters
Enhanced drug absorption can be achieved by reducing particle sizes and increasing surface areas, thereby facilitating...
Routes of Drug Administration: Enteral
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
